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Most adult stem cells, including hematopoietic stem
cells (HSCs), are maintained in a quiescent or resting
state in vivo. Quiescence is widely considered to be
an essential protective mechanism for stem cells
that minimizes endogenous stress caused by cellular
respiration andDNA replication.Wedemonstrate that
HSC quiescence can also have detrimental effects.
We found that HSCs have unique cell-intrinsic mech-
anisms ensuring their survival in response to ionizing
irradiation (IR), which include enhanced prosurvival
gene expression and strong activation of p53-medi-
atedDNAdamage response.We show that quiescent
andproliferatingHSCsareequally radioprotectedbut
use different types of DNA repair mechanisms. We
describe how nonhomologous end joining (NHEJ)-
mediatedDNA repair in quiescentHSCs is associated
with acquisition of genomic rearrangements, which
can persist in vivo and contribute to hematopoietic
abnormalities. Our results demonstrate that quies-
cence is a double-edged sword that renders HSCs
intrinsically vulnerable to mutagenesis following
DNA damage.
INTRODUCTION
DNA repair is essential for cell survival and maintenance of tissue
homeostasis (Lombard et al., 2005). Cellular organisms must
constantly contend with endogenous DNA damage caused by
intrinsic or extrinsic stresses and have evolved multiple DNA
repair systems to deal with these insults (Sancar et al. 2004).
DNA double-strand breaks (DSBs) are considered the most
cytotoxic type of DNA lesion and can arise during DNA replica-
tion or upon exposure to ionizing radiation (IR) and radiomimetic
chemicals. DSB formation triggers a global DNA damage
response resulting in the activation of the DNA damage sensor
ATM, which in turn activates cell cycle checkpoints and phos-
phorylates an array of downstream targets including the tumor
suppressor gene p53. This global DNA damage response174 Cell Stem Cell 7, 174–185, August 6, 2010 ª2010 Elsevier Inc.(DDR) is directed toward the cells’ own preservation and can
lead to growth arrest and initiation of DNA repair by specialized
DSB repair mechanisms, with programmed cell death being an
alternative outcome of excessive or unrepaired DNA damage.
The two principal and complementary mechanisms by which
eukaryotic cells repair DSBs are homologous recombination
(HR) and nonhomologous end joining (NHEJ) (Sancar et al.,
2004). HR-mediated DNA repair uses a template for accurate
repair, usually the sister chromatid, and thus can only occur in
cycling cells. In contrast, NHEJ-mediated DNA repair has a
limited requirement for sequence homology and can take place
at any stage of the cell cycle. NHEJ-type repair is a more error-
prone mechanism than the high-fidelity HR-type repair, which
often leads to misrepaired DSBs that may result in chromosomal
deletions, insertions or translocations, and subsequent genomic
instability (Weinstock et al., 2006). Although defects in DNA
damage responses have been associated with cancer, aging,
and stem cell abnormalities (Hanahan and Weinberg, 2000;
Park and Gerson, 2005), much remains to be learned about the
mechanism by which stem cells normally respond to DNA
damage and repair DSBs.
The hematopoietic system provides a uniquely tractable
model to investigate the activity of specific cell populations
(Orkin and Zon, 2008). Hematopoietic development is organized
hierarchically, starting with a rare population of hematopoietic
stem cells (HSCs) that gives rise to a series of committed
progenitors and mature cells with exclusive functional and
immunophenotypic properties. HSCs are the only cells within
the hematopoietic system that self-renew for life, whereas other
hematopoietic progenitors cells are short lived and committed to
the transient production of mature blood cells. Under steady-
state conditions, HSCs are a largely quiescent, slowly cycling
cell population, which, in response to environmental cues, are
capable of dramatic expansion and contraction to ensure proper
homeostatic replacement of blood cells. In this context, the
quiescent status of HSCs is widely considered to be an essential
protective mechanism that minimizes endogenous stress
caused by cellular respiration and DNA replication (Orford and
Scadden, 2008). Proper execution of DNA repair processes is
essential for normal HSC function. Mice lacking components
and regulators of the DNA damage response and DSB repair
mechanisms all display severe hematopoietic phenotypes and
HSC defects (Ito et al., 2004; Nijnik et al., 2007; Rossi et al.,
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spectrum of human blood disorders (Wang, 2007) and the occur-
rence of chromosomal translocations is a hallmark of human
hematological malignancies (Look, 1997). Previous studies
have shown that genotoxic insults such as ionizing radiation
(IR) differentially affect subsets of bone marrow hematopoietic
cells, with HSCs being more radioresistant than their down-
stream myeloid progeny (Meijne et al., 1991; Down et al.,
1995). This result is consistent with the low levels of intracellular
oxidative species (ROS) observed in HSCs compared to myeloid
progenitors (Tothova et al., 2007) and the well-established link
between irradiation-induced DNA damage and ROS generation.
However, limited information is currently available about the
precise DNA repair capacity of HSCs and myeloid progenitor
cells as well as on the mutagenic consequences of such repair
for their biological functions.
Here, we use flow cytometry to isolate a highly enriched
HSC-containing population referred to as hematopoietic stem
and progenitor cells (HSPCs) and two distinct subsets of myeloid
progenitors (MPs), the common myeloid progenitors (CMPs),
and the granulocyte/macrophage progenitors (GMPs). We
show that long-lived HSPCs have robust and unique cell-intrinsic
mechanisms to ensure their survival in response to IR exposure,
which include enhanced pro-survival gene expression and a
strong induction of p53-mediated DDR leading to growth arrest
and DNA repair, whereas short-lived MPs are molecularly poised
to undergo apoptosis and are predominantly eliminated in
response to genotoxic stress. Most importantly, we demonstrate
that HSPCs are forced to initiate DNA repair by using the error-
prone NHEJ mechanism because of their largely quiescent cell
cycle status and the molecular composition of their DNA repair
machinery. We show that this preferential use of NHEJ-mediated
DNA repair renders quiescent HSPCs susceptible to genomic
instability associated with misrepaired DNA, which can con-
tribute to HSC loss of function and/or pre-malignant transforma-
tion in vivo. In contrast, HSPCs that have been induced to prolif-
erate, either by in vitro culturing or in vivo mobilization treatment,
undergo DNA repair using the high-fidelity HR mechanism and
have a significantly decreased risk of acquiring mutation(s).
Taken together, our results demonstrate that HSC quiescence
is a double-edged sword, which on the one hand protects
HSCs against endogenous stress but, on the other hand, renders
HSCs intrinsically vulnerable to mutagenesis following DNA
damage.
RESULTS
Enhanced Radioresistance in HSPCs Compared to MPs
We first defined the radiosensitivity of our purified hematopoietic
stem and myeloid progenitor cells. We isolated HSPCs (Lin/
c-Kit+/Sca-1+/Flk2), CMPs (Lin/c-Kit+/Sca-1/CD34+/FcgR),
and GMPs (Lin/c-Kit+/Sca-1/CD34+/FcgR+) from the pooled
bone marrow of five to ten wild-type mice, exposed them to
increasing doses of IR (0–10 Gy) and performed clonogenic
survival assays in methylcellulose and liquid media (Figure 1A
and Figure S1 available online). We observed a striking difference
in colony numbers at the 2 Gy dose of irradiation, with HSPCs dis-
playing significantly enhanced radioresistance compared to MPs
that correlated with the differentiation status of the populationsanalyzed (HSPCs > CMPs > GMPs). At doses greater than
4 Gy, all three populations were equally radiosensitive and did
not form colonies, in agreement with the fact that the hematopoi-
etic system is one of the first organ systems to fail after total body
irradiation. To determine whether the enhanced radioresistance
of HSPCs results from cell-intrinsic differences in their DNA
damage response, we performed a similar clonogenic survival
assay with HSPCs and MPs isolated from Atm-deficient mice
(Ito et al., 2004) (Figure 1B). In contrast to wild type cells, we found
that Atm/ HSPCs, CMPs and GMPs all displayed matching
hypersensitivity to increasing doses of IR (0–4 Gy). These results
confirm that HSPCs are intrinsically more resistant to IR exposure
than CMPs and GMPs and indicate that ATM is an essential medi-
ator of this differential DNA damage response. We also showed
that Slam-HSCs (Lin/c-Kit+/Sca-1+/Flk2/CD150+/CD48),
one of the most pure HSC populations characterized so far,
display radioresistance similar to that of HSPCs (Figure S1),
which indicate that our analysis of HSPCs may be generalized
in this instance to HSC biology.
HSPCs Undergo Growth Arrest whereas MPs Die
in Response to IR Treatment
We then investigated the cellular outcomes (i.e., proliferation and
apoptosis responses) induced by 2 Gy IR in HSPCs and MPs.
CFSE dilution assays uncovered a profound delay in the division
rates of 2 Gy-irradiated HSPCs that was still evident 3 days after
IR exposure (Figure 1C). Although CMPs displayed an interme-
diate behavior, with a recovery of normal proliferation by
3–4 days after IR, the irradiation treatment had almost no effect
on GMP proliferation rates. We then measured the apoptotic
response occurring in these cells by using intracellular cleaved
caspase 3 (CC3) and Annexin V/7-AAD staining (Figure 1D and
data not shown). We found that unirradiated MPs had signifi-
cantly higher basal levels of CC3 staining compared to HSPCs
after 1 and 2 days in culture (1.3- and 8.5-fold higher in
CMPs and 3.7- and 10.4-fold higher in GMPs, respectively).
Furthermore, we observed a robust and immediate IR-mediated
apoptotic response in CMPs and GMPs but a minimal induction
of apoptosis 2 days after irradiation in HSPCs. To establish the
status of the apoptotic machinery in these cells, we performed
qRT-PCR analysis of the expression levels of a comprehensive
panel of bcl2 family pro- and antiapoptotic genes in freshly iso-
lated HSPCs, CMPs, and GMPs (Figure 1E). We observed an
overall deficit in prosurvival genes and a trend toward increased
expression of proapoptotic genes in MPs compared to HSPCs.
Using western blotting, we confirmed several highly significant
changes (p % 0.001) found at the mRNA level including
decreased Mcl-1 and increased Bid proteins in GMPs (Figure 1F).
To functionally test whether a deficit in prosurvival genes contrib-
utes to the higher rate of apoptosis in MPs, we isolated cells
from H2k-bcl2 transgenic mice (Domen et al., 2000) and evalu-
ated the effect of enhanced bcl2 expression on their apoptotic
response (Figure 1D). Whereas HSPCs remained essentially
unaffected by bcl2 overexpression, we observed a significant
decrease in the basal level of CC3 staining in MPs, especially
in GMPs. However, H2k-bcl2 MPs displayed an unchanged
IR-mediated apoptotic response, which suggests that overex-
pressing a single prosurvival gene cannot compensate for the
strength of IR-mediated death signals in MPs. Taken together,Cell Stem Cell 7, 174–185, August 6, 2010 ª2010 Elsevier Inc. 175
Figure 1. HSPCs Are Intrinsically Radiore-
sistant and Survive IR-Induced Cell Killing
(A) Clonogenic survival assay of irradiated cells in
methylcellulose (n = 9; ***p % 0.001 [CMPs and
GMPs versus HSPCs]; dp % 0.05 [GMPs versus
CMPs]).
(B) Clonogenic survival assay of irradiated Atm/
cells in methylcellulose (n = 3; *p % 0.05 [Atm+/+
GMPs versus Atm+/+ HSPCs]; p % 0.001
[Atm/ versus Atm+/+ populations]).
(C) Representative example of CFSE dilution
assay in unirradiated (gray) or 2 Gy-irradiated
(color) cells grown for up to 3 days in liquid media
(n = 4).
(D) Intracellular cleaved caspase 3 staining in unir-
radiated (gray) or 2 Gy-irradiated WT (left side;
solid colors; n = 10) or H2k-bcl2 (right side; striped
colors; n = 3) cells grown for up to 2 days in liquid
media (p% 0.001, *p% 0.05 [unirradiated versus
irradiated cells]; p % 0.001, p % 0.05 [H2k-
bcl2 versus WT cells]; ns, not significant).
(E) QRT-PCR analysis of the basal expression level
of bcl2-family prosurvival and proapoptotic genes
Trp53 and p21 in freshly isolated cells. Results are
expressed as log2 fold expression compared to
levels measured in HSPCs (n = 6; ***p % 0.001,
**p % 0.01, *p % 0.05 [CMPs versus HSPCs];
p% 0.001, p% 0.01, p% 0.05 [GMPs versus
HSPCs]).
(F) Western blot analysis of Mcl-1 and Bid protein
levels in purified cells (protein extracted from
35,000 isolated cells per lane; b-actin is used as
loading control).
Unpaired Student’s t test on means ± standard
deviations (error bars). See also Figure S1.
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(especially GMPs) are poised at the molecular level to undergo
apoptosis because of a deficit in prosurvival genes and are
mostly eliminated in response to IR treatment. In contrast, the
long-lived HSPCs predominantly survive and undergo growth
arrest after irradiation.
Dual Role of the p53 Pathway
p53 is an important downstream target of ATM, which can
mediate either growth arrest or apoptosis following DNA damage.
To determine whether HSPCs and MPs engage a p53-depen-
dent DDR, we first treated mice with 2 Gy IR and measured the
changes in p53 protein levels occurring in these bone marrow
compartments at 12 hours postirradiation by using intracellular
FACS analysis (Figure 2A). Although we observed stabilization
of p53 protein in in vivo-irradiated HSPCs, no significant changes
were found in irradiated MPs. We also confirmed by immuno-
blotting a 2-fold stronger phosphorylation of p53 (Ser15) in176 Cell Stem Cell 7, 174–185, August 6, 2010 ª2010 Elsevier Inc.HSPCs compare to MPs at 1 hr post-IR
in vitro and a trailing off in both popula-
tions by 4 hr post-IR (Figure S2). To
directly assess p53 activity in these com-
partments, we then measured the induc-
tion of p53 target genes (i.e, bax, noxa,
puma, and p21) by qRT-PCR with purifiedcells grown in liquid culture for 8 and 12 hr post-IR (Figure 2B).
Interestingly, the strength of the p53-mediated DDR (as mea-
sured by the levels of target gene induction) was much higher
and sustained for a longer time in HSPCs compared to the limited
and transient response observed in MPs, especially in GMPs.
We further confirmed the functional importance of p53 in both
HSPCs and MPs by using cells isolated from Trp53/ mice
(Liu et al., 2009). Analysis of Trp53/ HSPCs, CMPs, and GMPs
both in clonogenic survival assays and liquid culture (Figure 2C
and data not shown) revealed increased radioresistance in all
three populations. Furthermore, we showed that removal of
p53 prevents HSPCs from undergoing growth arrest after IR
exposure (Figure 2D), whereas in MPs, p53 deletion considerably
decreased the basal level and abrogated IR-mediated induction
of apoptosis (Figure 2E). As expected, p53-mediated induction of
p21 and bcl2 proapoptotic targets did not occur in irradiated
Trp53/ HSPCs and MPs (Figure 2F). Taken together, these
results highlight the dual role that p53 plays in modulating
Figure 2. Dual Role for p53-Mediated DNA
Damage Response in HSPCs and Myeloid
Progenitors
(A) Intracellular FACS analysis of p53 and actin
protein levels in unirradiated (IR) or 2 Gy irradi-
ated (+IR) mice 12 hr after exposure.
(B) QRT-PCR analysis of p53 target genes in WT
cells 8 and 12 hr after 2 Gy IR treatment. Results
are expressed as log2 fold expression compared
to levels measured in unirradiated cells cultured
in the same conditions (n = 3; ***p % 0.001,
**p % 0.01, *p % 0.05) or 12 hr (n = 3; p %
0.001, p% 0.01, p% 0.05).
(C) Clonogenic survival assay of irradiated
Trp53/ cells in methylcellulose (n = 3; **p %
0.01, *p% 0.05 [Trp53/ vs. Trp53+/+ cells]).
(D) Example of CFSE dilution assay in unirradiated
(IR: gray) or 2 Gy-irradiated (+IR: blue) Trp53+/+
(solid) and Trp53/ (striped) HSPCs grown for
2 days in liquid media (n = 3).
(E) Intracellular cleaved caspase 3 staining in
unirradiated (gray) or 2 Gy-irradiated Trp53+/+
(solid colors) and Trp53/ (striped colors) cells
grown for up to 2 days in liquid media (n = 3;
***p% 0.001, ** p% 0.01, *p% 0.05 [unirradiated
versus irradiated cells]; p % 0.01, p % 0.05
[Trp53/ versus Trp53+/+ cells]; ns: not signifi-
cant).
(F) QRT-PCR analysis of p53-target genes in
Trp53/ cells 12 hours after 2 Gy IR treatment.
Results are expressed as log2 fold expression
compared to levels measured in unirradiated
Trp53-/- cells cultured in the same conditions
(n = 3).
Unpaired Student’s t test on means ± standard
deviations (error bars).See also Figure S2.
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that in HSPCs the high basal level of prosurvival genes coupled
with the strong p53-mediated induction of p21 protect against
the killing effects of increased proapoptotic gene expression,
resulting mainly in growth arrest as already observed in other
cellular contexts (Abbas and Dutta, 2009). In contrast, in MPs,
the limited induction of proapoptotic genes that occurs in the
context of very low basal levels of prosurvival genes and in the
absence of or with weak induction of p21 results predominantly
in cell death.
Ongoing DNA Repair in HSPCs
To determine the extent of DSB DNA repair in irradiated HSPCs
and MPs, we first used immunofluorescence microscopy to
quantify gH2AX-containing ionizing radiation-induced foci
(IRIF), which form at the sites of DNA damage (Figure 3A). Unir-
radiated HSPCs and MPs all displayed extremely low levels ofCell Stem Cell 7, 174–185, August 6, 2010 ª2010 Elsevier Inc. 177l
.
r
t
tIRIF and, after exposure to 2 Gy IR,
showed an immediate induction of
gH2AX-positive DNA damage foci. By
4–24 hr post-IR, the numbers of IRIF
declined in HSPCs with relatively faster
kinetics than in MPs. To determine
whether the loss of gH2AX foci corre-
sponded to ongoing DNA repair or simplyreflected cell elimination, we next subjected unirradiated and
irradiated cells to an alkaline COMET assay and scored the tai
DNA content on a 0 (undamaged) to 4 (very damaged) scale to
assess the severity of the resulting DNA damage (Figure 3B)
We started this assay with identical numbers of cells for all condi-
tions and normalized the tail DNA content score for the numbers
of cells actually detected on the agarose slides, to account fo
the observation that dying cells are often lost during the various
steps of this experimental procedure. Quantification of the
results revealed that all three populations acquired equivalen
amounts of DNA damage 2 hr after irradiation (Figure 3C and
Table S1). By 24 hr post-IR, we observed a significant shif
toward less damaged tail DNA content scores in HSPCs, which
occurred without overall loss of cells thereby demonstrating
active ongoing DNA repair. In contrast, in MPs, we predomi-
nantly observed cell elimination, with the persistence of only
undamaged cells or a few cells undergoing DNA repair. Taken
Figure 3. Ongoing DNA Repair in HSPCs
versus Cell Elimination in Myeloid Progeni-
tors
(A) Immunofluorescence microscopy of ionizing
radiation-induced foci (IRIF) of gH2AX in unirradi-
ated or 2 Gy-irradiated HSPCs (n = 13), CMPs
(n = 8) and GMPs (n = 10). The percentage of posi-
tive cells (R6 gH2AX positive foci) is shown over
24 hours (*p % 0.05 [CMPs versus HSPCs];
p % 0.001 [GMPs versus HSPCs]; scale bar
represents 10 mm).
(B) Representative examples of COMET tail DNA
content scoring from undamaged (0) and increas-
ingly damaged (1–3) to very damaged (4) cells.
(C) Quantification of tail DNA content scores in
unirradiated or 2 Gy-irradiated HSPCs, CMPs
and GMPs after 2 and 24 hr. Results are normal-
ized to the number of cells counted per field
(n = 3; **p% 0.01).
Unpaired Student’s t test on means ± standard
deviations (error bars).See also Table S1.
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survive and undergo DNA repair, and confirm that the majority
of irradiated MPs are eliminated. They also highlight the fact
that the decrease in gH2AX staining can be skewed because
of the confounding impact of cell death (as in MPs) and, although
marking the resolution of DSBs (as in HSPCs), cannot simply be
equated with complete DNA repair.
Preferential Use of NHEJ Repair Mechanism
in Quiescent HSPCs
We then investigated the type of DSB repair mechanisms used
by irradiated HSPCs and the few surviving MPs. To assess HR
activity, we quantified IRIF containing the Rad51 recombinase
protein by immunofluorescence microscopy. Unfortunately,
none of the components of the NHEJ machinery that we exam-
ined (Ku70, Ku80) were detectable by microscopy in IRIF (data178 Cell Stem Cell 7, 174–185, August 6, 2010 ª2010 Elsevier Inc.not shown). Therefore, as a surrogate,
we quantified IRIF containing the 53BP1
DNA damage response protein as
53BP1 has been shown to function, albeit
not exclusively, in NHEJ. Rad51 IRIF
formation occurred rapidly in irradiated
MPs, reaching its maximum (50% of
the cells) by 2 hr (CMPs) and 4 hr
(GMPs) post-IR and then remaining
unchanged for up to 24 hr (Figure 4A). In
contrast, no significant Rad51 recruit-
ment was observed in HSPCs until 24 hr
post-IR. This staining pattern is consis-
tent with the proliferation index of the
respective populations (Figure S3), with
irradiated HSPCs being mostly quiescent
at the start of the culture and only initi-
ating their first cell division by  24 hours
in vitro (Figure 1C). Conversely, recruit-
ment of 53BP1 in IRIF occurred immedi-
ately in all three populations but then
declined at a slower rate in HSPCs (Fig-ure 4B). To support these observations, we also analyzed the
basal expression level of HR and NHEJ components in freshly
isolated HSPCs, CMPs, and GMPs (Figure 4C). Strikingly, we
found that all of the HR components and/or regulators we inves-
tigated were expressed at significantly higher levels in MPs
compared to HSPCs, whereas the NHEJ machinery components
were either dramatically decreased (Ku80) or unchanged in MPs.
Finally, we used a reporter assay in which the religation of a di-
gested plasmid expressing the enhanced green fluorescent
protein (eGFP) allowed a measurement of the NHEJ activity
present at baseline and after IR in transfected cells (Figure S4).
Consistent with the predominance of NHEJ as a repair mecha-
nism in HSPCs, we observed high basal levels of NHEJ activity
in unirradiated HSPCs and a 2-fold increase after irradiation
(Figure 4D and Figure S4). In sharp contrast, GMPs displayed
extremely low basal levels and no IR-mediated induction of
Figure 4. High NHEJ-Mediated DNA Repair
Mechanism in HSPCs
(A) Immunofluorescence microscopy of Rad51
IRIF in unirradiated and 2Gy-irradiated HSPCs
(n = 5), CMPs (n = 6) and GMPs (n = 8). The
percentage of positive cells (R 3 Rad51 positive
foci) is shown over 24 hours (***p% 0.001, **p%
0.01, *p % 0.05 [CMPs versus HSPCs]; p %
0.001, p % 0.05 [GMPs versus HSPCs]; scale
bar represents 10 mm).
(B) Immunofluorescence microscopy of 53BP1
IRIF in unirradiated and 2 Gy-irradiated HSPCs
(n = 9), CMPs (n = 7), and GMPs (n = 9). The
percentage of positive cells (R3 53BP1 positive
foci) is shown over 24 hr (***p % 0.001, *p %
0.05 [CMPs versus HSPCs]; p% 0.001, p%
0.01 [GMPs versus HSPCs]; scale bar represents
10 mm).
(C) QRT-PCR analysis of homologous recombina-
tion (HR) and nonhomologous end joining (NHEJ)
DNA repair genes in freshly isolated cells. Results
are expressed as log2 fold expression compared
to levels measured in HSPCs (n = 3; ***p %
0.001, *p % 0.05 [CMPs vs. HSPCs]; p %
0.001, p% 0.01, p% 0.05 [GMPs vs. HSPCs]).
(D) Quantification of NHEJ activity in unirradiated
and 2 Gy-irradiated cells. Results are expressed
as fold changes upon IR treatment (n = 5; ***p %
0.001, **p% 0.01).
Unpaired Student’s t test on means ± standard
deviations (error bars).See also Figures S3 and S4.
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basal and IR-mediated NHEJ activity. Taken together, these
results demonstrate that HSPCs are forced to initiate DNA repair
with NHEJ-type mechanisms because of their largely quiescent
cell cycle status and the molecular wiring of their DNA repair
machinery. They also indicate that the few proliferating MPs
that escape IR-mediated cell killing are molecularly primed to
undergo HR-mediated DNA repair and do not use NHEJ-type
mechanisms.
HSPC Radioprotection Is Independent of Quiescence
It has been suggested that quiescence provides HSCs with
enhanced resistance to genotoxic stress (Tothova et al., 2007;
Orford and Scadden, 2008). To experimentally test this assump-
tion, we forced HSPCs to proliferate before exposing them to
2 Gy IR (Figure 5A). First, we precultured resting HSPCs (‘‘Rest.
HSPCs’’) for  24 hours in vitro (‘‘24hr preC HSPCs’’) to induce
their proliferation and, second, we used an in vivo mobilizationCell Stem Cell 7, 174–18treatment (Passegue´ et al., 2005) to
harvest proliferating bone marrow HSPCs
(‘‘Mob. HSPCs’’) after one injection of
cyclophosphamide and 2 days of stimula-
tion with G-CSF. Both strategies resulted
in a net increase in HSPC cycling rates
as measured after a 1 hr BrdU pulse (Fig-
ure 5B) and a loss of quiescence as
measured by intracellular 7AAD/PyroninY
staining (Figure 5C). Strikingly, no differ-
ences were observed in the radioresist-ance of proliferating HSPCs compared to resting HSPCs with
either clonogenic survival assay in methylcellulose (Figure 5D)
or proliferation in liquid culture (Figure 5E). At the molecular level,
we found that proliferating HSPCs had decreased basal levels of
prosurvival genes, varied levels of proapoptotic genes, and
constitutively higher apoptosis rates than quiescent HSPCs
(Figure S5 and Figure 5F). However, like quiescent HSPCs, prolif-
erating HSPCs did not show a significant IR-mediated apoptotic
response (Figure 5F), but unlike quiescent HSPCs, they did not
undergo IR-mediated growth arrest and displayed an attenuated
p53-mediated response including limited induction of p21
expression (Figure 5G and Figure S5). Altogether, these results
indicate a major rewiring of the DNA damage response in pro-
liferating HSPCs to one that closely resembles the response
observed in MPs. However, this does not result in an analogous
loss of radioresistance suggesting that proliferative HSPCs still
retain additional, yet unexplored, protective mechanism(s) that
are not shared by their more differentiated progeny.5, August 6, 2010 ª2010 Elsevier Inc. 179
Figure 5. Similar Radioresistance in Quies-
cent and Proliferating HSPCs
(A) In vitro 24 hour preculture (24hr preC) and
in vivo cyclosphosphamide/G-CSF mobilization
(Mob.) strategies used to induce proliferation of
quiescent (Rest.) HSPCs.
(B) Proliferation rates measured after 1 hr BrdU
pulse in vitro (n = 3; dddp % 0.001; [proliferating
HSPCs versus resting HSPCs]).
(C) Quiescence status measured by intracellular
7AAD/Pyronin Y staining.
(D) Clonogenic survival assay in methylcellulose
(n = 3).
(E) Growth in liquid media (n = 3).
(F) Intracellular cleaved caspase 3 staining in unir-
radiated (gray) or 2 Gy-irradiated (color) resting
and proliferating HSPCs grown for up to 2 days
in liquid media (n = 3; ***p % 0.001, **p % 0.01,
*p% 0.05 [proliferating HSPCs ± IR versus resting
HSPCs ± IR]; ns, not significant).
(G) Example of CFSE dilution assay in unirradiated
(gray) or 2 Gy-irradiated (color) quiescent and
proliferating HSPCs grown for 2 days in liquid
media (n = 3).
Unpaired Student’s t test on means ± standard
deviations (error bars). See also Figure S5.
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Next, we investigated the type of DNA repair mechanisms that
were used by 2 Gy-irradiated proliferating HSPCs. We observed
similar kinetics of gH2AX IRIF induction and resolution in both
resting and proliferating HSPCs, indicating that they are equally
efficient at repairing IR-induced DSBs (Figure S5). However, in
contrast to quiescent HSPCs, proliferating HSPCs immediately
formed Rad51 IRIF, which reached maximum levels by 2–4 hr
post-IR and remained elevated throughout the 24 hr experiment
(Figure 6A). 53BP1 recruitment to IRIF also occurred immediately
in proliferating HSPCs but sharply declined thereafter and
returned to basal levels by 12 hr post-IR, in contrast to the slow
decline seen in resting HSPCs (Figure 6B). Consistent with the
rewiring of the DNA damage response, we also found increased
expression of HR genes and decreased expression of NHEJ
components in proliferating HSPCs compared to quiescent
HSPCs (Figure 6C). Although the basal levels of NHEJ activity180 Cell Stem Cell 7, 174–185, August 6, 2010 ª2010 Elsevier Inc.were not significantly different in unirradi-
ated cells (Figure S4), we observed a com-
plete abrogation of IR-mediated induction
of NHEJ activity in proliferating HSPCs
compared to resting HSPCs (Figure 6D).
Taken together, these results demon-
strate that quiescence dramatically re-
stricts HSPCs’ ability to use the high-
fidelity HR-mediated repair and instead
forces them to rely on the more error-
prone NHEJ mechanism to repair DSBs.
Quiescent HSPCs Are Prone
to Acquire Mutations
NHEJ-mediated repair can be mutagenic
in many ways, most commonly by causingdeletion of microhomology sequences flanking the breakpoint or
insertions at the DSB joint region. Given that IR can induce
DSBs anywhere in the genome, we used fluorescence in situ
hybridization (FISH) in an attempt to determine whether NHEJ-
mediated mutagenic repair could result in molecular-level dele-
tions within a fragile chromosomal region, leading to loss of
hybridization signals. Unirradiated and 2 Gy-irradiated quiescent
HSPCs were grown in culture for 4 to 5 days for maximal expan-
sion, treated for 4 hr with Colcemid, and fixed for cytogenetic
studies, and interphase cells were then hybridized with a probe
for the mouse Fhit locus common fragile site. No significant differ-
ence in signal intensity could be observed between unirradiated
and irradiated cells using this approach (FigureS6). More sensitive
techniques will therefore be required to assess these particular
forms of mutagenic NHEJ-mediated DSBs repair. NHEJ has
also been shown to be very proficient at mediating chromosomal
translocations, whereas HR-type repair are not because of
Figure 6. Proliferating HSPCs Shift to
HR-Mediated DNA Repair Mechanism
(A) Immunofluorescence microscopy of Rad51
IRIF in 2 Gy-irradiated resting HSPCs (n = 5),
24 hr precultured HSPCs (n = 3) and mobilized
HSPCs (n = 5). The percentage of positive cells
(R3 Rad51 positive foci) is shown over 24 hr
(***p % 0.001, *p % 0.05 [24h preC. versus Rest.
HSPCs]; p% 0.001 [Mob. versus Rest. HSPCs];
scale bar represents 10 mm).
(B) Immunofluorescence microscopy of 53BP1
IRIF in 2 Gy-irradiated resting HSPCs (n = 9),
24 hr precultured HSPCs (n = 3) and mobilized
HSPCs (n = 5). The percentage of positive cells
(R 3 53BP1 positive foci) is shown over 24 hr
(***p % 0.001 [24hr preC. versus Rest. HSPCs];
p % 0.001, p % 0.01 [Mob. versus Rest.
HSPCs]; scale bar represents 10 mm).
(C) QRT-PCR analysis of HR and NHEJ repair
genes in resting and proliferating HSPCs (n = 3;
***p % 0.001, **p % 0.01, *p % 0.05 [24h preC
versus Rest. HSPCs]; p % 0.001, p % 0.01,
p% 0.05 [Mob. versus Rest. HSPCs]).
(D) Quantification of NHEJ activity in unirradiated
and 2 Gy-irradiated resting and proliferating
HSPCs. Results are average ± SEM (error bars)
of two (24h preC. and Mob. HSPCs) to five (Rest.
HSPCs) independent experiments and are ex-
pressed as fold changes upon IR treatment
(*p% 0.05).
Unpaired Student’s t test on means ± standard
deviations (error bars) otherwise indicated. See
also Figures S4 and S5.
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whether the progeny of IR-treated resting HSPCs could acquire
major genomic rearrangements as the result of inaccurate
NHEJ-mediated DNA repair, and whether the frequency of such
mutagenic events would be decreased in HR-competent, prolifer-
ating HSPCs, we performed spectral karyotyping (SKY) analysis
on the metaphase cells obtained from the same cell preparations
(Figure 7A). Strikingly, we found that more than 30% of the cells
derived from IR-treated resting HSPCs consistently displayed
major genomic rearrangements, including reciprocal transloca-
tions, interstitial deletions, and complex rearrangements,
compared to unirradiated cells (Figure 7B and Table S2). Most
importantly, we showed that induction of proliferation and the
availability of HR-mediated DNA repair in both 24h preC. and
Mob. HSPCs significantly reduced the number and frequency of
genomic aberrations occurring upon IR exposure, hence
decreasing by half the risk of acquiring genomic instability in the
self-renewing HSPC compartment (Figure 7C and Table S2).
Taken together, these results provide a direct demonstration
that IR-damaged HSPCs, which are limited to using NHEJ-repair
mechanismby theirquiescent status,areprone toacquire cytoge-
netic aberrations as a result of incorrectly repaired DNA damage.
Persistence of Misrepaired HSPCs In Vivo
We then tested whether such misrepaired HSPCs could persist
in vivo and eventually contribute to hematological disorders.We transplanted unirradiated or irradiated quiescent HSPCs
(CD45.1) immediately after IR exposure into lethally irradiated
WT (CD45.2) recipient mice and monitored them over 4 months
after transplantation for development of hematological abnor-
malities and genomic instability (Figure 7C). As expected, we
observed a dose-dependent decrease in engraftment of IR-
exposed HSPCs compared to unirradiated HSPCs, with no
long-term hematopoietic reconstitution provided by 6 Gy-
treated HSPCs (data not shown). At 4 months after transplanta-
tion, none of the engrafted mice developed leukemia or showed
outward signs of hematological abnormalities in the peripheral
blood and bone marrow (data not shown). CD45.1 donor-derived
HSPCs and MPs were then isolated from pools of mice reconsti-
tuted with 2 Gy-irradiated HSPCs and used, respectively, for
secondary transplantation and SKY analysis. In three out of
four 2 Gy-treated HSPC cohorts, a significant number of
donor-derived MPs displayed genomic abnormalities including
the presence of the same t(16;17) balanced chromosomal trans-
location in55% of cohort I2 donor-derived MPs (Figure 7E and
Table S3). This result indicates the clonal expansion of a single
mutated HSPC. The complete loss of engraftment that was
observed after secondary transplantation of donor-derived
cohort I2 HSPCs (Figure 7E) further suggests the presence of a
mutation(s) associated with HSC exhaustion and bone marrow
failure. Taken together, these findings indicate that misrepaired
HSPCs can survive at relatively high frequencies in vivo andCell Stem Cell 7, 174–185, August 6, 2010 ª2010 Elsevier Inc. 181
Figure 7. Mutagenic DNA Repair in Quies-
cent HSPCs
(A) Summary of the SKY analyses performed on
the in vitro progeny of 2 Gy-irradiated quiescent
HSPCs.
(B) Average number of genomic rearrangement
(left side) and percentage (%) of aberrant cells
(right side) identified by SKY analysis in the
in vitro progeny of 2 Gy-irradiated quiescent
(Rest.; n = 4) and proliferating (Mob./24h preC;
n = 3) HSPCs (*p% 0.05).
(C) Experimental design of the in vivo analysis of 2
Gy-irradiated HSPCs assessing long-term recon-
stitution and genomic instability.
(D) Summary of the SKY analysis performed on the
in vivo MP progeny of 2 Gy-irradiated quiescent
HSPCs 4 months after transplantation.
(E) In cohort I2, 1,500 ±IR HSPC together with
300,000 Sca-1-depleted helper bone marrow cells
were transplanted per recipient (n = 5 [0Gy] and 4
[2Gy] mice per group). Long-term reconstitution
was measured by sustained CD45.1 chimerism
in the peripheral blood of primary transplanted
mice (left graph; expressed as percentage of the
engraftment provided by unirradiated HSPCs)
and secondary transplantation of donor-derived
HSPCs reisolated from pooled primary trans-
planted animals (right graph; expressed as
engraftment ratio of CD45.1+ cells at 4 months
posttransplantation; n = 4 [0Gy] and 5 [2Gy] mice
per group).
Unpaired Student’s t test on means ± standard
deviations (error bars). See also Figure S6 and
Tables S2 and S3.
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DNA Repair in Hematopoietic Stem Cellscan contribute either to the direct expansion of aberrant clones
(as in cohort I2) or, more often, to the maintenance of a back-
ground of genomic alterations (as in cohorts I3 and I4), some
of which could be premalignant.
DISCUSSION
Defects in DNA damage responses that cause accumulation of
DNA damage and loss of DNA repair capacity are broadly
associated with organ failure, cancer, aging, and stem cell
abnormalities (Hanahan and Weinberg, 2000; Park and Gerson,
2005). The decline in tissue function observed with age has
also been correlated with impaired stem cell activity (Chambers
and Goodell, 2007; Geiger and Rudolph, 2009). However, much
remains to be elucidated about the mechanisms by which DNA
damage is repaired in adult stem cells and whether mutation(s)
arising from aberrant repair contribute to aging and/or suscepti-
bility to cancer in these self-renewing populations. In this study,
we investigated how blood-forming HSCs respond to DNA-
damaging IR exposure, determined the extent to which they
use the error-prone NHEJ repair mechanism, and assessed the182 Cell Stem Cell 7, 174–185, August 6, 2010 ª2010 Elsevier Inc.consequences of such mutagenic DNA
repair for their biological functions. We
identify some of the key molecular mech-
anisms that ensure HSCs resistance to
IR-mediated cell killing and provide a
mechanistic explanation for why HSCsare at greater risk of accumulating mutations than other cells in
the hematopoietic system. Our results demonstrate that the
prevalent DNA repair mechanism active in quiescent HSCs is
prone to generating mutations.
Long-lived HSCs are essential for hematopoietic homeostasis
and, as we show here, have unique cell-intrinsic mechanisms
ensuring their survival (Figure S7). These probably include
enhanced prosurvival gene expression and robust induction of
DNA damage checkpoints (i.e., ATM, p53) leading to a strong
p53-mediated induction of both proapoptotic genes (i.e., bax,
nova, and puma) and p21 expression. We postulate that high
basal levels of prosurvival factors probably limit IR-mediated
cell killing in HSCs and instead favor p21-mediated growth
arrest, DNA repair, and survival as has already been observed
in other cellular contexts (Abbas and Dutta, 2009). This promi-
nent role for p21 in normal HSCs may explain why it has been
found to have such an important function in maintaining the
DNA damage response and self-renewal properties of leukemic
HSCs transformed by the PML-RAR oncogene (Viale et al.,
2009). Interestingly, we show that normal HSCs that have been
induced to proliferate either by in vitro culturing or in vivo
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bcl2-family prosurvival genes and display constitutively higher
levels of apoptosis than quiescent HSCs. However, this rewiring
of the apoptotic machinery does not result in loss of radioprotec-
tion nor in any significant increase in IR-mediated cell killing of
proliferating HSCs, as observed in MPs, which indicates that
additional, still unexplored, survival mechanism(s) also con-
tribute to the specific protection of this self-renewing compart-
ment. It is likely that maintenance of low levels of ROS (Tothova
et al., 2007) and other fundamental mechanisms of cellular
detoxification contribute to the enhanced survival of long-lived
HSCs. It will also be interesting to confirm that endogenous
HSCs in the bone marrow space display the same behavior after
radiation insults than isolated HSCs ex vivo.
In terms of organ maintenance, it is logical to keep long-lived
HSCs quiescent in vivo to guard them against DNA replication
errors and damage associated with oxidative stress (Rossi
et al., 2007; Orford and Scadden, 2008). Our ex vivo analyses
demonstrate that a substantial limitation of HSC quiescence is
reduced elimination of damaged HSCs by apoptosis and an
increased likelihood of mutagenesis due to the use of error-
prone DNA repair mechanisms (Figure S7). This conclusion is
further supported by the observation that HR-competent prolif-
erating HSCs have significantly decreased risk of acquiring
mutation(s), which probably results from their use of a high-
fidelity repair mechanism. Our transplantation experiments
directly demonstrate that damaged HSCs, which have under-
gone DNA repair and acquired mutation(s) during this process,
can persist in vivo at relatively high frequencies and contribute
either to the clonal expansion of aberrant cells or to the mainte-
nance of cells with genomic alterations. Both events could
predispose mutated HSCs to loss of function and/or cancer
development and their occurrence is probably due to the
stochastic combination of cell-intrinsic effects provided by the
acquired mutation(s) and selection pressure in vivo. Although
we have analyzed only a small number of transplanted cohorts
thus far, we observed at least one case of each of the two
possible mutagenic outcomes: mutation(s) providing either
growth or survival advantages that are clonally amplified (cohort
I2) and, more frequently, nonessential ‘‘passenger’’ mutation(s)
that appear to be maintained but not expanded in vivo (cohorts
I3 and I4). These results are consistent with the cytogenetic
pattern of human hematological malignancies, where only
a handful of recurring translocations, deletions, and inversions
are associated with specific diseases (Look, 1997) and clonally
expanded in the context of either a high or low background of
genomic alterations (Radtke et al., 2009). They also extend the
conclusion of a previous study performed with multipotent
hematopoietic cells differentiated in vitro from mouse embryonic
stem cells (ESCs), which showed that immature hematopoietic
progenitors were particularly susceptible to the formation of
chromosomal rearrangements analogous to those found in
human hematological malignancies (Francis and Richardson,
2007). Moreover, our findings suggest that vulnerability to muta-
genesis might be a general property of all quiescent stem cell
populations either normal or cancerous. They highlight why
quiescent leukemic stem cells (LSCs), which currently survive
therapeutic treatment in chronic myelogenous leukemia (CML)
(Holyoake et al., 1999) and acute myeloid leukemia (AML)(Guan et al., 2003), represent a dangerous reservoir for additional
mutations that is likely to contribute to disease relapse and/or
evolution.
Our results provide the beginning of a molecular under-
standing of why HSCs are more likely than MPs to become trans-
formed and trigger leukemia development (Bonnet and Dick,
1997). In contrast to HSCs, transformation of MPs must
overcome significant self-destructive mechanisms. MPs are
short-lived cells that are constantly replenished from the HSC
compartment and are therefore expendable in terms of organ
maintenance. Our results indicate that MPs are intrinsically
poised to die and are mainly eliminated in response to DNA
damage (Figure S7). When compared to HSCs, MPs have a
much-attenuated p53-mediated DDR. However, despite its
limited extent, p53-mediated induction of proapoptotic genes
is not counter-balanced by high basal levels of prosurvival
factors as seen in HSCs and occurs with only a weak induction
of p21, thereby leading mostly to cell elimination. As a conse-
quence, mutations resulting in transformation of the MP com-
partment are unlikely to become established unless the cells
gain substantial survival advantage(s) either by inheriting muta-
tions from the HSC compartment (as observed with BCR/ABL1
during CML progression) (Jamieson et al., 2004) or by directly
acquiring leukemia-associated fusion genes with major ‘‘re-
programming’’ activity, such as MLL translocations (Krivtsov
et al., 2006).
Our results may also explain some aspects of the loss of
function occurring in HSCs with age. Age-related defects in the
hematopoietic system include a decline in the adaptive immune
system called immunosenescence and the development of a
broad spectrum of age-related hematological disorders (i.e.,
myeloproliferative neoplasms, leukemia, lymphoma, and bone
marrow failure) that have been linked to changes in the biological
function of aged HSCs (Chambers and Goodell, 2007; Geiger
and Rudolph, 2009). Gene expression studies and analysis of
genetically modified mice also indicate that errors in DNA repair
and poorly maintained genomic stability are among the main
driving forces for HSC aging (Rossi et al., 2007). Our findings
suggest that accumulation of NHEJ-mediated mutation(s) over
a lifetime could dramatically hinder HSC performance and be
a major contributor to the loss of function observed in aged
HSCs and the development of age-related hematological
disorders.
Finally, our results may have direct clinical applications for
minimizing the development of therapy-related cancers after
cytotoxic therapy (Allan and Travis, 2005). Many solid tumors
and hematological malignancies are currently treated with DNA
damaging agents, which may result in therapy-related myeloid
leukemia. Our work suggests that cytotoxic therapies might
inadvertently mutate the patient’s own quiescent HSCs by
forcing them to undergo DNA repair using a mutagenic mecha-
nism. Specifically, we show that proliferating HSCs have signifi-
cantly decreased mutation rates, with no observed changes in
their radioresistance, suggesting that it might be beneficial to
induce HSCs to cycle prior to therapy with DNA damaging
agents to enhance DNA repair fidelity and reduce the risk of
leukemia development. Although this possibility remains to be
tested, it offers exciting new directions for limiting the deleterious
side effects of cancer treatment.Cell Stem Cell 7, 174–185, August 6, 2010 ª2010 Elsevier Inc. 183
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Mice
Wild-type C57Bl/6-CD45.1 and C57Bl/6-CD45.2 mice were used as donors
(4–8 weeks old) for cell isolation and as recipient (8–12 weeks old) for cell
transplantation. Atm/ mice (129/sv) were purchased from the Jackson
Laboratory and both transgenic H2k-bcl2 (C57Bl/6) and Trp53/ (FVB/N)
mice have been described (Domen et al., 2000; Liu et al., 2009). Cyclo-
phosphamide/G-CSF mobilization of HSCs was performed as described
(Passegue´ et al., 2005).
Flow Cytometry
Cell staining and enrichment for cell sorting of HSPCs, CMPs, and GMPs were
performed as described (Passegue´ et al., 2005; Santaguida et al., 2009). Each
population was double-sorted to ensure maximum purity and irradiated with
a 137Cs source.
Cell Proliferation, Apoptosis, and Colony Formation
Cells were either plated in methylcellulose and counted on day 7 with duplicate
plates per condition or grown in liquid culture and counted on days 2, 4, 6, and
8 with triplicate wells per condition and time point. Both methylcellulose and
liquid cultures were supplemented with IL-3, GM-CSF, IL-11, Flt3-L, SCF,
EPO, and TPO as described. Flow cytometry was used for assessing
apoptosis levels by intracellular staining for cleaved caspase 3, and prolifera-
tion rates by CFSE dilution assay, BrdU incorporation and 7AAD/Puronin Y
staining in accordance with the manufacturer’s instructions and as described
(Santaguida et al., 2009).
Gene Expression and Protein Analyses
RNA extraction, cDNA preparation, and qRT-PCR analysis were performed as
described (Santaguida et al., 2009). The cDNA equivalent of 200 cells was
used per reaction, each measurement was performed in triplicate, and values
were normalized to b-actin expression. Western blot analyses were performed
with the protein content of 35,000–70,000 purified cells (% 5 mg total protein)
per lane.
Immunofluorescence Microscopy, COMET, and Cytogenetic Assays
For immunofluorescence staining, cells were cytospun onto poly-lysine
coated slides, fixed, permeabilized, and stained as described (Dodson et al.,
2004). For the alkaline COMET assay, cells were embedded in agarose on
slides and tested as previously described (Klaude et al., 1996). For cytogenetic
studies, cultured cells were treated with 0.01 mg/ml Colcemid for 4 hr,
fixed, and analyzed by FISH or SKY as previously described (Le Beau et al.,
2002).
Statistics
Unpaired Student’s t test on means ± standard deviations (error bars). n indi-
cates the numbers of independent experiments performed.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, four tables, and Supple-
mental Experimental Procedures and can be found with this article online at
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